Reappraising prognostic factors after SRS/FSRT of brain metastases in the era of targeted therapies

被引：0
|
作者：
Fink, Christoph A. [1 ]
Tawk, Bouchra [1 ]
Hahnemann, Laura [1 ]
Christopoulos, Petros [2 ]
Hoerner-Rieber, Juliane [1 ]
Weykamp, Fabian [1 ]
Lang, Kristin [1 ]
Thomas, Michael [2 ]
Debus, Juergen [1 ]
Koenig, Laila [1 ]
机构：
[1] Univ Hosp Heidelberg, Radiat Oncol, Heidelberg, Germany
[2] Dept Thorac Oncol, Thoraxklin, Heidelberg, Germany
来源：
RADIOTHERAPY AND ONCOLOGY | 2024年 / 194卷
关键词：
targeted therapy; checkpoint inhibition; SRS;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1044
引用
收藏
页码：S816 / S819
页数：5
相关论文
共 50 条
  • [41] FSRT vs. SRS in Brain Metastases-Differences in Local Control and Radiation Necrosis-A Volumetric Study
    Putz, Florian
    Weissmann, Thomas
    Oft, Dominik
    Schmidt, Manuel Alexander
    Roesch, Johannes
    Siavooshhaghighi, Hadi
    Filimonova, Irina
    Schmitter, Charlotte
    Mengling, Veit
    Bert, Christoph
    Frey, Benjamin
    Lettmaier, Sebastian
    Distel, Luitpold Valentin
    Semrau, Sabine
    Fietkau, Rainer
    FRONTIERS IN ONCOLOGY, 2020, 10
  • [42] Radiosurgery (SRS) and fractionated stereotactic radiotherapy (FSRT) for re-irradiation of brain metastases: results in 36 patients (pts)
    Rossi, R
    Maranzano, E
    Chirico, L
    Trippa, F
    Basagni, ML
    Italiani, M
    Muti, M
    RADIOTHERAPY AND ONCOLOGY, 2004, 73 : S434 - S434
  • [43] Survival and prognostic factors for patients with melanoma brain metastases in the era of modern systemic therapy
    Tio, Martin
    Wang, Xuan
    Carlino, Matteo S.
    Shivalingam, Brindha
    Fogarty, Gerald B.
    Guminski, Alexander D.
    Lo, Serigne
    Hong, Angela M.
    Menzies, Alexander M.
    Long, Georgina V.
    PIGMENT CELL & MELANOMA RESEARCH, 2018, 31 (04) : 509 - 515
  • [44] Genetic Characterization of Brain Metastases in the era of Targeted Therapy
    Han, Catherine H.
    Brastianos, Priscilla K.
    FRONTIERS IN ONCOLOGY, 2017, 7
  • [45] Prognostic factors for patients with brain metastases
    Le Scodan, Romuald
    Massard, Christophe
    Noel, Georges
    BULLETIN DU CANCER, 2013, 100 (01) : 45 - 50
  • [46] Reirradiation of brain metastases with SRS after local or marginal recurrence from prior SRS
    Kowalchuk, R.
    Niranjan, A.
    Lee, C.
    Yang, H.
    Liscak, R.
    Guseynova, K.
    Tripathi, M.
    Kumar, N.
    Peker, S.
    Samanci, Y.
    Hess, J.
    Chang, V.
    Iorio-Morin, C.
    Mathieu, D.
    Pikis, S.
    Wei, Z.
    Lunsford, L.
    Trifiletti, D.
    Sheehan, J.
    RADIOTHERAPY AND ONCOLOGY, 2021, 161 : S46 - S47
  • [47] Analysis of Prognostic Factors Affecting the Brain Metastases Free Survival and Survival After Brain Metastases in Breast Cancer
    Xiao Weikai
    Li Xuerui
    Yang Anli
    Chen Bo
    Zheng Shaoquan
    Zhang Guochun
    Deng Wenju
    Liao Ning
    FRONTIERS IN ONCOLOGY, 2020, 10
  • [48] Management of brain metastases in lung cancer: evolving roles for radiation and systemic treatment in the era of targeted and immune therapies
    Myall, Nathaniel J.
    Yu, Helena
    Soltys, Scott G.
    Wakelee, Heather A.
    Pollom, Erqi
    NEURO-ONCOLOGY ADVANCES, 2021, 3 : V52 - V62
  • [49] Survival in melanoma brain metastases in the era of novel systemic therapies
    Merola, Joseph P.
    Ocen, Joanita
    Kumar, Satish
    Powell, James
    Hayhurst, Caroline
    NEURO-ONCOLOGY ADVANCES, 2020, 2 (01)
  • [50] The Stereotactic Radiosurgery-Brain Prognostic Index (SRS-BPI): A novel prognostic index for lung cancer patients with brain metastases eligible for SRS
    Koulouris, A. V.
    Skribek, M. C.
    Kamali, C.
    Grundberg, O.
    Lampa, E.
    Gubanski, M.
    Hydbring, P.
    Ekman, S.
    Tsakonas, G.
    ANNALS OF ONCOLOGY, 2024, 35 : S858 - S858
12345